Cytokinetics CYTK Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's common stock?
- Cytokinetics (CYTK) reported common stock of $124K in Q1 2026.
- How has Cytokinetics's common stock changed year-over-year?
- Cytokinetics's common stock increased by 4.2% year-over-year, from $119K to $124K.
- What is the long-term trend for Cytokinetics's common stock?
- Over 5 years (2020 to 2025), Cytokinetics's common stock has grown at a 11.9% compound annual growth rate (CAGR), from $70K to $123K.
- What does common stock mean?
- The total par value of the company's basic ownership shares.
- How do you interpret common stock?
- Changes in this value typically reflect stock issuances for capital raises or employee compensation programs.
- How does common stock compare across companies?
- Standard equity line item across all publicly traded companies.